Concepedia

Suma Krishnan

SK

Statistics

Publications

17

Citations

2.2K

H-Index

17

Active since

2001

Affiliations

Center for Diagnosis and Research on Alzheimer's Disease(Current)

Center for Psychiatry and Behavioral Medicine

Stanford University

Takeda (United States)

Thomas Jefferson University

Suma Krishnan is an author at Center for Diagnosis and Research on Alzheimer's Disease specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

2001–2022

17

Publications

17

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

Joseph Biederman, Suma Krishnan, Yuxin Zhang et al. · Clinical Therapeutics · 2007 · 402 citations

, , +10

Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study

Joseph Biederman, Samuel W. Boellner, Ann Childress et al. · Biological Psychiatry · 2007 · 357 citations

, , +8

Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

Lenard A. Adler, D. Wayne Goodman, Scott H. Kollins et al. · The Journal of Clinical Psychiatry · 2008 · 219 citations

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

Shireen V. Guide, Mercedes E. González, Işın Sinem Bağcı et al. · New England Journal of Medicine · 2022 · 167 citations

Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse

DR Jasinski, Suma Krishnan · Journal of Psychopharmacology · 2009 · 149 citations

1–5 of 17